Table 2.
as a function of GBTM-DVR | |||||||||
---|---|---|---|---|---|---|---|---|---|
Primary set | Sensitivity set 1 | Sensitivity set 2 | |||||||
Predictors | Estimates | CI | P | Estimates | CI | P | Estimates | CI | P |
Intercept | 0.00 | −0.08–0.08 | 0.968 | 0.00 | −0.12–0.12 | 0.972 | 0.00 | −0.08–0.08 | 0.984 |
GBTM-DVR | 0.83 | 0.75–0.90 | <0.001 | 0.46 | 0.35–0.56 | <0.001 | 0.83 | 0.75–0.90 | <0.001 |
Random effects | |||||||||
σ2 | 0.12 | 0.32 | 0.12 | ||||||
τ00 | 0.25 Reggieid | 0.52 Reggieid | 0.25 Reggieid | ||||||
ICC | 0.67 | 0.62 | 0.67 | ||||||
N | 165 Reggieid | 173 Reggieid | 165 Reggieid | ||||||
Observations | 515 | 530 | 509 | ||||||
Marginal R2/conditional R2 | 0.648/0.885 | 0.200/0.695 | 0.649/0.885 | ||||||
as a function of age, moderated by binary PiB status | |||||||||
Intercept | 0.23 | 0.20–0.27 | <0.001 | 0.27 | 0.21–0.34 | <0.001 | 0.23 | 0.20–0.27 | <0.001 |
Amyloid positivity | 0.19 | 0.13–0.24 | <0.001 | 0.16 | 0.06–0.26 | 0.002 | 0.19 | 0.13–0.24 | <0.001 |
Age (centred), linear | 0.00 | −0.00–0.00 | 0.337 | 0.00 | −0.00–0.01 | 0.267 | 0.00 | −0.00–0.00 | 0.350 |
Amyloid positivity × age (centred), linear | 0.02 | 0.02–0.03 | <0.001 | 0.01 | 0.00–0.03 | 0.021 | 0.02 | 0.02–0.03 | <0.001 |
Random effects | |||||||||
σ2 | 0.01 | 0.05 | 0.01 | ||||||
τ00 | 0.03 Reggieid | 0.09 Reggieid | 0.03 Reggieid | ||||||
ICC | 0.81 | 0.66 | 0.81 | ||||||
N | 165 Reggieid | 173 Reggieid | 165 Reggieid | ||||||
Observations | 515 | 530 | 509 | ||||||
Marginal R2/conditional R2 | 0.355/0.879 | 0.093/0.695 | 0.356/0.878 |
GBTM-DVR = group-based trajectory modelled distribution volume ratio from amyloid PET; ICC = intraclass correlation; = phosphorylated tau 217.
Bold text denotes statistical significance.